CCL2 and inflammatory bowel disease: Through gene expression analyses of colon tissue, we identified significant increases in markers of tumor progression and microenvironment regulation, including LGR5, TWIST1, SNAIL, IL-8, CCL2, and COX2, in the colon of PSC patients compared with those with IBD alone.